Files in This Item:


Title: Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients
Authors: Shidfar, F.
Keshavarz, A.
Hosseyni, S.
Ameri, A.
Yarahmadi, S.
Issue Date: 2008
Language: English
Abstract: In order to test whether hyperlipidaemia and glycaemic control can be improved among diabetes patients by dietary supplementation with purified omega-3 fatty acids, we carried out a doubleblind, placebo-controlled trial on 50 type 2 diabetes patients randomized to 2 g/day purified omega-3 fatty acids or placebo for 10 weeks. Fasting triglycerides decreased significantly with supplementation relative to placebo [P = 0.01]. There was a significant decrease in ApoB-100 and malondialdehyde compared to baseline values and compared to the control group. Omega-3 fatty acids had no significant effect on serum lipid levels, ApoA-I, glucose, insulin and HbA1[c]
Description: 305-313
Keywords: Lipids
Diabetes Mellitus, Type 2
Blood Glucose
Double-Blind Method
Subject: Fatty Acids, Omega-3
ISSN: 1020-3397
Other Identifiers:
Appears in Collections:EMRO Journal Articles (EMHJ)

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.